| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |